Trial intelligence / Profile preview

Intensive insulin-based blood glucose control in acute COPD exacerbations

2007-004956-35Phase 4Terminated

Sponsor
St George's, University of London
Start
Nov 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of human insulin in chronic obstructive pulmonary disease (COPD) and Stress Hyperglycemia (SH), sponsored by St George's, University of London. Primary endpoint: Severe hypoglycaemia. Started Nov 2007; status: terminated.

02

Drugs

human insulin
03

Conditions

chronic obstructive pulmonary disease (COPD)Stress Hyperglycemia (SH)

Beyond the preview

Go deeper on 2007-004956-35.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004956-35.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call